[Guidelines in the management of H. pylori infection in Japan--2009 version].
The results of a large-scale multicenter study conducted by Japanese H. pylori investigators were published in the Lancet in 2008. Patients after endoscopic treatment for early gastric cancer were randomized to eradication and non-eradication groups for investigation of recurrence after 3 years, demonstrating that recurrence was markedly inhibited in the eradication group. The question asked all over the world about whether H. pylori eradication can inhibit the onset of gastric cancer could be definitely answered by these results. For preparation of these guidelines, the addition of H. pylori infection as an indication for eradication was discussed, and it was unanimously accepted as an additional indication.